Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hausheer BioMed
Austin, Texas, USAhausbiomed.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Hausheer BioMed provides expert consulting, research, and advisory services in oncology drug development, patent validity, clinical trial design (Phase I–III), regulatory compliance (FDA/EMA/NMPA/PMDA), pharmacology, and medical safety. The company leverages decades of executive leadership by Dr. Frederick H. Hausheer across global pharmaceutical R&D with a focus on novel cancer therapeutics including cytotoxic agents, targeted therapies, immuno-oncology drugs, cell therapies such as BMT/CAR-Ts, and supportive care medicines. There are no disclosed proprietary clinical results or pipeline assets under the company's name.
Dr. Frederick H. Hausheer has been involved as CEO/founder with other companies developing late-stage oncology drugs but those programs belong to separate entities such as BioNumerik Pharmaceuticals.
The company appears to operate primarily as an expert witness/advisory firm rather than a traditional biotech/drug developer.
Pipeline information below reflects lack of internal R&D programs.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeCell therapyImmuno-oncology therapeuticsBiologic
- Industry
- Consulting
Beyond the preview
Go deeper on Hausheer BioMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hausheer BioMed.